1Ohlsson A,Walia R,Shah S.Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants [ J ].Cochrane Datebase Syst Rev,2003,(2):3481.
2van Overmeire B,Smets K,Lecoutere D,et al.A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus[ J ].N Engl J Med,2000,343:674-681.
3Raju NV,Bharadwaj RA,Thonas R,et al.Ibuprofen use to reduce the incidence and severity of bronchopulmonary dysplasia:a pilot study[J].J Perinatol,2000,1:13-16.
4van Overmeire B,Touw D,Schepens PJC,et al.Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus[J ].Clin Pharmacol Ther,2001,70:336-343.
5Sharma PK,Garg Sk,Narang A.Pharmacokinetics of oral ibuprofen in premature infants[ J ].J Clin Pharmacol,2003,43 (9):968-973.
6Heyman E,Morag I,Batash D,et al.Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns:a pilot study[ J ].Pediatrics,2003,112 (3):354-358.
7Itabashi K,Ohno T,Nishida H.Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin[ J ].J Pediatr,2003,143(2):203-207.
8Thomas RL,Parker GC,van Overmeire B.A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus [J].Eur J Pediatr,2005,164(3):135-140.
9Gournay V,Savagner C,Thiriez G,et al.Pulmonary hypertension after ibuprofen prophylaxis in very low preterm infants [ J ].Lancet,2002,359:1486-1488.
